Harvard Biotech Guru, VCs Launch With $55 Million Series A

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Harvard Biotech Guru, VCs Launch LifeMine Therapeutics With $55 Million Series A" ALT"Harvard Biotech Guru, VCs Launch LifeMine Therapeutics With $55 Million Series A"September 18, 2017By Mark Terry,…

Continue ReadingHarvard Biotech Guru, VCs Launch With $55 Million Series A

<b>Kaleido Biosciences</b> Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Former Cubist Exec" ALT"Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will…

Continue Reading<b>Kaleido Biosciences</b> Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec

Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks4.jpg" NAME"Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics" ALT"Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics"September 18, 2017By…

Continue ReadingBay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics

Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC" ALT"Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC"September 15, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Continue ReadingMassachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC

Show Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Show Me The Money: Bay Areas Top 5 Venture Capital-Backed Biotechs" ALT"Show Me The Money: Bay Areas Top 5 Venture Capital-Backed Biotechs"September 15, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingShow Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs

Novartis AG Unloads Former New York Space for $18 Million, Resold for $30 Million

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x600-novartis.jpg" NAME"Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million" ALT"Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million"September 15, 2017By…

Continue ReadingNovartis AG Unloads Former New York Space for $18 Million, Resold for $30 Million